GSK’s Dovato suppresses AIDS virus at same levels of three-drug regimen

13

GlaxoSmithKline Plc’s two-drug HIV regimen Dovato was successful in suppressing the AIDS-causing virus in patients for six months at the same level of a previous three-drug treatment in a late-stage study, the drugmaker said on Wednesday.

http://feeds.reuters.com/~r/reuters/healthNews/~3/RqLKWOCtZpo/gsks-dovato-suppresses-aids-virus-at-same-levels-of-three-drug-regimen-idUSKCN1U50KV

- Advertisement -